These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Detection and occurrence of chlorinated byproducts of bisphenol a, nonylphenol, and estrogens in drinking water of china: comparison to the parent compounds.
    Author: Fan Z, Hu J, An W, Yang M.
    Journal: Environ Sci Technol; 2013 Oct 01; 47(19):10841-50. PubMed ID: 24011124.
    Abstract:
    This study applied a sensitive dansylation LC-MS/MS method to the investigation on the occurrence of bisphenol A (BPA), nonylphenol (NP), estrogens (E1 and E2), and their 11 chlorinated byproducts in 62 drinking water treatment plants (DWTPs) of 31 major cities across China. BPA (4.7-512 ng/L), NP (8.2-918 ng/L), and E1 (ND-9.9 ng/L) were widely detected in source waters, E2 was detected in less than half of the samples (ND-3.2 ng/L), while chlorinated byproducts were only detected in source waters of two DWTPs. In drinking water, chlorinated BPAs and monochloro-NP (MCNP) were detected in more than half of the samples with concentrations of 0.2-26.7 ng/L for monochloro-BPA (MCBPA), ND-6.3 ng/L for dichloro-BPA (DCBPA), ND-7.7 ng/L for trichloro-BPA (TCBPA), ND-4.8 ng/L for tetrachloro-BPA (TBBPA), and ND-13.3 ng/L for MCNP, while dichloro-E1 (DCE1, ND-0.2 ng/L) and dichloro-NP (DCNP, ND-1.6 ng/L) were less frequently detected (10/62 and 4/62). The production of chlorinated NPs in DWTPs was mainly influenced by the amount of NP in source water and chlorine added, while the concentrations of chlorinated BPAs in drinking waters were only found to be significantly correlated with those of BPA in source waters. Advanced treatment processes could be effective techniques for reducing target chlorinated byproducts in drinking water. This is the first report on the occurrence of chlorinated byproducts of BPA, NP, and estrogens in drinking water, and these chemicals should be considered when assessing the human risk of their parent compounds.
    [Abstract] [Full Text] [Related] [New Search]